Begor Mark W 4

What Happened

• Mark W. Begor, CEO and Director of Equifax Inc. (EFX), exercised 37,791 stock options at $112.46 per share (total exercise cost $4,249,976) on April 24, 2026 (transaction code M). The same 37,791 shares were sold in multiple open-market transactions that day (transaction code S), generating total proceeds of about $6,515,209 (weighted average sale price ≈ $172.45/share).
• Net effect: Begor acquired shares via option exercise and disposed of the same number of shares the same day; the sales were carried out under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: April 24, 2026 (reported on Form 4 filed 4/28/2026 — filing appears timely).
• Exercise: 37,791 shares at $112.46 = $4,249,976 (code M).
• Sales (all on 4/24/2026): four tranches totaling 37,791 shares for combined proceeds $6,515,209 (individual weighted-average tranche prices reported: $174.32, $173.39, $171.57, $172.46; price ranges for each tranche are provided in the filing).
• Footnotes: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted 10/28/2025 (F1). Several footnotes note weighted-average prices and the underlying price ranges for each tranche (F3–F6). F7 notes the option vested in three equal annual increments beginning 5/4/2019. F2 describes how certain holdings include reinvested dividend equivalents and ESPP purchases.
• Shares owned after the transactions: not specified in the supplied excerpt of the Form 4 (see the full filing for post-transaction holdings).

Context

• This filing shows an option exercise followed by same-day sales of the exercised shares — a common pattern when insiders exercise options and sell shares to cover exercise costs, taxes, or rebalance holdings. The sales here were executed under a 10b5-1 plan, which is a pre-arranged trading program that can allow insiders to sell shares while limiting claims of opportunistic timing.
• The filing is factual and does not indicate insider motivation. Purchases generally carry more explicit bullish signal than routine option exercises followed by sales; this transaction appears to be an exercise plus disposition rather than a new bullish buy.